Association of Mortality, Hospitalization, and Impaired Recovery with Adverse Cardiac Magnetic Resonance Phenotypes in Hypertrophic Cardiomyopathy Patients post-covid-19: An HCMR Analysis

• Betty Raman, MD, PhD,
• Paul Kolm, PhD,
• Brian Case, MD,
• Ryan Wallace, MD,
• Sarahfaye Dolman, MPH,
• William Weintraub, MD,
• Milind Desai, MD,
• John Di Marco, MD,
• Patrice Desvigne-Nickens, MD,
• Nancy Geller,
• Carolyn Ho, MD,
• Dong-Yun Kim, PhD,
• Christopher Kramer, MD,
• Stefan Neubauer, MD, PhD

Affiliations

Betty Raman, MD, PhD

Oxford Centre for Clinical Magnetic Resonance Research

Paul Kolm, PhD

MedStar Health Research Institute

Brian Case, MD

MedStar Health Research Institute and Georgetown University

Ryan Wallace, MD

MedStar Health Research Institute and Georgetown University

Sarahfaye Dolman, MPH

MedStar Health Research Institute and Georgetown University

William Weintraub, MD

MedStar Health Research Institute and Georgetown University

Milind Desai, MD

Cleveland Clinic

John Di Marco, MD

University of Virginia Health, Charlottesville, Virginia, USA.

Patrice Desvigne-Nickens, MD

National Heart, Lung, and Blood Institute, National Institutes of Health

Nancy Geller

National Heart, Lung, and Blood Institute, National Institutes of Health

Carolyn Ho, MD

Brigham and Women's Hospital

Dong-Yun Kim, PhD

National Heart, Lung, and Blood Institute, National Institutes of Health

Christopher Kramer, MD

University of Virginia

Stefan Neubauer, MD, PhD

Oxford Centre for Clinical Magnetic Resonance Research